0409110901: ATRACURIUM BESYLATE INJECTION.
The ATRACURIUM BESYLATE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, primary_container_type: VIAL, SINGLE DOSE, secondary_container_type: BOX, primary_container_content_quantity: 5.0 MILLILITERS, part_name_assigned_by_controlling_agency: ATRACURIUM BESYLATE INJECTION USP 50MG/5ML (10MG/ML), primary_container_quantity_per_secondary_container: 10 VIAL, SINGLE DOSE. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-719-0697, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| primary_container_type | VIAL, SINGLE DOSE |
| secondary_container_type | BOX |
| primary_container_content_quantity | 5.0 MILLILITERS |
| part_name_assigned_by_controlling_agency | ATRACURIUM BESYLATE INJECTION USP 50MG/5ML (10MG/ML) |
| primary_container_quantity_per_secondary_container | 10 VIAL, SINGLE DOSE |
| NSN | 6505-01-719-0697 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.0 MILLILITERS |
| SECONDARY CONTAINER TYPE | BOX |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ATRACURIUM BESYLATE INJECTION USP 50MG/5ML (10MG/ML) |
| PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 10 VIAL, SINGLE DOSE |